English
简体中文
Total: £ 56.28
Published Date: 2026-04-13 | Pages: 112 | Tables: 117 | Pharma & Healthcare
The global Malignant Ascites Treatment market was valued at US$ 554 million in 2025 and is anticipated to reach US$ 766 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
The most common malignancies associated with the development of ascites include cancers of the colon/rectum, ovary, breast, lung, pancreas, liver and lymphoma. Treatment strategies include paracentesis, diuretics and peritoneovenous shunts and so on.
Global Malignant Ascites Treatment key players include BD, B. Braun, Pfizer, Merit Medical Systems, Pfm Medical Ag, etc. Global top five manufacturers hold a share about 40%. North America is the largest market, with a share about 30%, followed by Europe and Middle East & Africa, both have a share about 60 percent. In terms of product, Paracentesis is the largest segment, with a share over 65%.
This report delivers a comprehensive overview of the global Malignant Ascites Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Malignant Ascites Treatment. The Malignant Ascites Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Malignant Ascites Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Malignant Ascites Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
BD
Pfizer
B. Braun
Merit Medical Systems
Pfm Medical Ag
Medtronic
CMP Pharma
GI Supply (Laborie Medical Technologies)
The Surgical Company Group
Sequana Medical
PharmaCyte Biotech
BioVie
Clover Biopharmaceuticals
Segment by Type
Paracentesis
Chemotherapy
Surgical Treatment
Others
Segment by Application
Hospitals
Clinics
Homecare
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Malignant Ascites Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Malignant Ascites Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Paracentesis
1.2.3 Chemotherapy
1.2.4 Surgical Treatment
1.2.5 Others
1.3 Market by Application
1.3.1 Global Malignant Ascites Treatment Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Malignant Ascites Treatment Market Perspective (2021–2032)
2.2 Global Malignant Ascites Treatment Growth Trends by Region
2.2.1 Global Malignant Ascites Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Malignant Ascites Treatment Historic Market Size by Region (2021–2026)
2.2.3 Malignant Ascites Treatment Forecasted Market Size by Region (2027–2032)
2.3 Malignant Ascites Treatment Market Dynamics
2.3.1 Malignant Ascites Treatment Industry Trends
2.3.2 Malignant Ascites Treatment Market Drivers
2.3.3 Malignant Ascites Treatment Market Challenges
2.3.4 Malignant Ascites Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Malignant Ascites Treatment Players by Revenue
3.1.1 Global Top Malignant Ascites Treatment Players by Revenue (2021–2026)
3.1.2 Global Malignant Ascites Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top Malignant Ascites Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Malignant Ascites Treatment Revenue
3.4 Global Malignant Ascites Treatment Market Concentration Ratio
3.4.1 Global Malignant Ascites Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Malignant Ascites Treatment Revenue in 2025
3.5 Global Key Players of Malignant Ascites Treatment Head Offices and Areas Served
3.6 Global Key Players of Malignant Ascites Treatment, Products and Applications
3.7 Global Key Players of Malignant Ascites Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Malignant Ascites Treatment Breakdown Data by Type
4.1 Global Malignant Ascites Treatment Historic Market Size by Type (2021–2026)
4.2 Global Malignant Ascites Treatment Forecasted Market Size by Type (2027–2032)
5 Malignant Ascites Treatment Breakdown Data by Application
5.1 Global Malignant Ascites Treatment Historic Market Size by Application (2021–2026)
5.2 Global Malignant Ascites Treatment Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Malignant Ascites Treatment Market Size (2021–2032)
6.2 North America Malignant Ascites Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Malignant Ascites Treatment Market Size by Country (2021–2026)
6.4 North America Malignant Ascites Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Malignant Ascites Treatment Market Size (2021–2032)
7.2 Europe Malignant Ascites Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Malignant Ascites Treatment Market Size by Country (2021–2026)
7.4 Europe Malignant Ascites Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Malignant Ascites Treatment Market Size (2021–2032)
8.2 Asia-Pacific Malignant Ascites Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Malignant Ascites Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific Malignant Ascites Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Malignant Ascites Treatment Market Size (2021–2032)
9.2 Latin America Malignant Ascites Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Malignant Ascites Treatment Market Size by Country (2021–2026)
9.4 Latin America Malignant Ascites Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Malignant Ascites Treatment Market Size (2021–2032)
10.2 Middle East & Africa Malignant Ascites Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Malignant Ascites Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa Malignant Ascites Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Malignant Ascites Treatment Introduction
11.1.4 BD Revenue in Malignant Ascites Treatment Business (2021–2026)
11.1.5 BD Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Malignant Ascites Treatment Introduction
11.2.4 Pfizer Revenue in Malignant Ascites Treatment Business (2021–2026)
11.2.5 Pfizer Recent Development
11.3 B. Braun
11.3.1 B. Braun Company Details
11.3.2 B. Braun Business Overview
11.3.3 B. Braun Malignant Ascites Treatment Introduction
11.3.4 B. Braun Revenue in Malignant Ascites Treatment Business (2021–2026)
11.3.5 B. Braun Recent Development
11.4 Merit Medical Systems
11.4.1 Merit Medical Systems Company Details
11.4.2 Merit Medical Systems Business Overview
11.4.3 Merit Medical Systems Malignant Ascites Treatment Introduction
11.4.4 Merit Medical Systems Revenue in Malignant Ascites Treatment Business (2021–2026)
11.4.5 Merit Medical Systems Recent Development
11.5 Pfm Medical Ag
11.5.1 Pfm Medical Ag Company Details
11.5.2 Pfm Medical Ag Business Overview
11.5.3 Pfm Medical Ag Malignant Ascites Treatment Introduction
11.5.4 Pfm Medical Ag Revenue in Malignant Ascites Treatment Business (2021–2026)
11.5.5 Pfm Medical Ag Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Malignant Ascites Treatment Introduction
11.6.4 Medtronic Revenue in Malignant Ascites Treatment Business (2021–2026)
11.6.5 Medtronic Recent Development
11.7 CMP Pharma
11.7.1 CMP Pharma Company Details
11.7.2 CMP Pharma Business Overview
11.7.3 CMP Pharma Malignant Ascites Treatment Introduction
11.7.4 CMP Pharma Revenue in Malignant Ascites Treatment Business (2021–2026)
11.7.5 CMP Pharma Recent Development
11.8 GI Supply (Laborie Medical Technologies)
11.8.1 GI Supply (Laborie Medical Technologies) Company Details
11.8.2 GI Supply (Laborie Medical Technologies) Business Overview
11.8.3 GI Supply (Laborie Medical Technologies) Malignant Ascites Treatment Introduction
11.8.4 GI Supply (Laborie Medical Technologies) Revenue in Malignant Ascites Treatment Business (2021–2026)
11.8.5 GI Supply (Laborie Medical Technologies) Recent Development
11.9 The Surgical Company Group
11.9.1 The Surgical Company Group Company Details
11.9.2 The Surgical Company Group Business Overview
11.9.3 The Surgical Company Group Malignant Ascites Treatment Introduction
11.9.4 The Surgical Company Group Revenue in Malignant Ascites Treatment Business (2021–2026)
11.9.5 The Surgical Company Group Recent Development
11.10 Sequana Medical
11.10.1 Sequana Medical Company Details
11.10.2 Sequana Medical Business Overview
11.10.3 Sequana Medical Malignant Ascites Treatment Introduction
11.10.4 Sequana Medical Revenue in Malignant Ascites Treatment Business (2021–2026)
11.10.5 Sequana Medical Recent Development
11.11 PharmaCyte Biotech
11.11.1 PharmaCyte Biotech Company Details
11.11.2 PharmaCyte Biotech Business Overview
11.11.3 PharmaCyte Biotech Malignant Ascites Treatment Introduction
11.11.4 PharmaCyte Biotech Revenue in Malignant Ascites Treatment Business (2021–2026)
11.11.5 PharmaCyte Biotech Recent Development
11.12 BioVie
11.12.1 BioVie Company Details
11.12.2 BioVie Business Overview
11.12.3 BioVie Malignant Ascites Treatment Introduction
11.12.4 BioVie Revenue in Malignant Ascites Treatment Business (2021–2026)
11.12.5 BioVie Recent Development
11.13 Clover Biopharmaceuticals
11.13.1 Clover Biopharmaceuticals Company Details
11.13.2 Clover Biopharmaceuticals Business Overview
11.13.3 Clover Biopharmaceuticals Malignant Ascites Treatment Introduction
11.13.4 Clover Biopharmaceuticals Revenue in Malignant Ascites Treatment Business (2021–2026)
11.13.5 Clover Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Malignant Ascites Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Paracentesis
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Surgical Treatment
Table 5. Key Players of Others
Table 6. Global Malignant Ascites Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Malignant Ascites Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Malignant Ascites Treatment Market Size by Region (US$ Million), 2021–2026
Table 9. Global Malignant Ascites Treatment Market Share by Region (2021–2026)
Table 10. Global Malignant Ascites Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Malignant Ascites Treatment Market Share by Region (2027–2032)
Table 12. Malignant Ascites Treatment Market Trends
Table 13. Malignant Ascites Treatment Market Drivers
Table 14. Malignant Ascites Treatment Market Challenges
Table 15. Malignant Ascites Treatment Market Restraints
Table 16. Global Malignant Ascites Treatment Revenue by Players (US$ Million), 2021–2026
Table 17. Global Malignant Ascites Treatment Market Share by Players (2021–2026)
Table 18. Global Top Malignant Ascites Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Malignant Ascites Treatment Revenue, 2025
Table 19. Ranking of Global Top Malignant Ascites Treatment Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Malignant Ascites Treatment Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Malignant Ascites Treatment, Headquarters and Area Served
Table 22. Global Key Players of Malignant Ascites Treatment, Products and Applications
Table 23. Global Key Players of Malignant Ascites Treatment, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Malignant Ascites Treatment Market Size by Type (US$ Million), 2021–2026
Table 26. Global Malignant Ascites Treatment Revenue Market Share by Type (2021–2026)
Table 27. Global Malignant Ascites Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Malignant Ascites Treatment Revenue Market Share by Type (2027–2032)
Table 29. Global Malignant Ascites Treatment Market Size by Application (US$ Million), 2021–2026
Table 30. Global Malignant Ascites Treatment Revenue Market Share by Application (2021–2026)
Table 31. Global Malignant Ascites Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Malignant Ascites Treatment Revenue Market Share by Application (2027–2032)
Table 33. North America Malignant Ascites Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Malignant Ascites Treatment Market Size by Country (US$ Million), 2021–2026
Table 35. North America Malignant Ascites Treatment Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Malignant Ascites Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Malignant Ascites Treatment Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Malignant Ascites Treatment Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Malignant Ascites Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Malignant Ascites Treatment Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Malignant Ascites Treatment Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Malignant Ascites Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Malignant Ascites Treatment Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Malignant Ascites Treatment Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Malignant Ascites Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Malignant Ascites Treatment Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Malignant Ascites Treatment Market Size by Country (US$ Million), 2027–2032
Table 48. BD Company Details
Table 49. BD Business Overview
Table 50. BD Malignant Ascites Treatment Product
Table 51. BD Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 52. BD Recent Development
Table 53. Pfizer Company Details
Table 54. Pfizer Business Overview
Table 55. Pfizer Malignant Ascites Treatment Product
Table 56. Pfizer Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 57. Pfizer Recent Development
Table 58. B. Braun Company Details
Table 59. B. Braun Business Overview
Table 60. B. Braun Malignant Ascites Treatment Product
Table 61. B. Braun Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 62. B. Braun Recent Development
Table 63. Merit Medical Systems Company Details
Table 64. Merit Medical Systems Business Overview
Table 65. Merit Medical Systems Malignant Ascites Treatment Product
Table 66. Merit Medical Systems Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 67. Merit Medical Systems Recent Development
Table 68. Pfm Medical Ag Company Details
Table 69. Pfm Medical Ag Business Overview
Table 70. Pfm Medical Ag Malignant Ascites Treatment Product
Table 71. Pfm Medical Ag Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 72. Pfm Medical Ag Recent Development
Table 73. Medtronic Company Details
Table 74. Medtronic Business Overview
Table 75. Medtronic Malignant Ascites Treatment Product
Table 76. Medtronic Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 77. Medtronic Recent Development
Table 78. CMP Pharma Company Details
Table 79. CMP Pharma Business Overview
Table 80. CMP Pharma Malignant Ascites Treatment Product
Table 81. CMP Pharma Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 82. CMP Pharma Recent Development
Table 83. GI Supply (Laborie Medical Technologies) Company Details
Table 84. GI Supply (Laborie Medical Technologies) Business Overview
Table 85. GI Supply (Laborie Medical Technologies) Malignant Ascites Treatment Product
Table 86. GI Supply (Laborie Medical Technologies) Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 87. GI Supply (Laborie Medical Technologies) Recent Development
Table 88. The Surgical Company Group Company Details
Table 89. The Surgical Company Group Business Overview
Table 90. The Surgical Company Group Malignant Ascites Treatment Product
Table 91. The Surgical Company Group Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 92. The Surgical Company Group Recent Development
Table 93. Sequana Medical Company Details
Table 94. Sequana Medical Business Overview
Table 95. Sequana Medical Malignant Ascites Treatment Product
Table 96. Sequana Medical Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 97. Sequana Medical Recent Development
Table 98. PharmaCyte Biotech Company Details
Table 99. PharmaCyte Biotech Business Overview
Table 100. PharmaCyte Biotech Malignant Ascites Treatment Product
Table 101. PharmaCyte Biotech Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 102. PharmaCyte Biotech Recent Development
Table 103. BioVie Company Details
Table 104. BioVie Business Overview
Table 105. BioVie Malignant Ascites Treatment Product
Table 106. BioVie Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 107. BioVie Recent Development
Table 108. Clover Biopharmaceuticals Company Details
Table 109. Clover Biopharmaceuticals Business Overview
Table 110. Clover Biopharmaceuticals Malignant Ascites Treatment Product
Table 111. Clover Biopharmaceuticals Revenue in Malignant Ascites Treatment Business (US$ Million), 2021–2026
Table 112. Clover Biopharmaceuticals Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Malignant Ascites Treatment Picture
Figure 2. Global Malignant Ascites Treatment Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Malignant Ascites Treatment Market Share by Type: 2025 vs 2032
Figure 4. Paracentesis Features
Figure 5. Chemotherapy Features
Figure 6. Surgical Treatment Features
Figure 7. Others Features
Figure 8. Global Malignant Ascites Treatment Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Malignant Ascites Treatment Market Share by Application: 2025 vs 2032
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Homecare Case Studies
Figure 13. Others Case Studies
Figure 14. Malignant Ascites Treatment Report Years Considered
Figure 15. Global Malignant Ascites Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Malignant Ascites Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Malignant Ascites Treatment Market Share by Region: 2025 vs 2032
Figure 18. Global Malignant Ascites Treatment Market Share by Players in 2025
Figure 19. Global Malignant Ascites Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Malignant Ascites Treatment Revenue in 2025
Figure 21. North America Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Malignant Ascites Treatment Market Share by Country (2021–2032)
Figure 23. United States Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Malignant Ascites Treatment Market Share by Country (2021–2032)
Figure 27. Germany Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Malignant Ascites Treatment Market Share by Region (2021–2032)
Figure 35. China Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Malignant Ascites Treatment Market Share by Country (2021–2032)
Figure 43. Mexico Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Malignant Ascites Treatment Market Share by Country (2021–2032)
Figure 47. Israel Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Malignant Ascites Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. BD Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 51. Pfizer Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 52. B. Braun Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 53. Merit Medical Systems Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 54. Pfm Medical Ag Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 55. Medtronic Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 56. CMP Pharma Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 57. GI Supply (Laborie Medical Technologies) Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 58. The Surgical Company Group Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 59. Sequana Medical Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 60. PharmaCyte Biotech Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 61. BioVie Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 62. Clover Biopharmaceuticals Revenue Growth Rate in Malignant Ascites Treatment Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
